PBP
Pharmaceuticals, Biotechnology & Life Sciences
Probiotec
- Short interest
- 0.07%
- +0.07 pp 30d
- as of 17 June 2024
- Reported shorts
- 57.4K
- Shares on issue
- 81.323M
Probiotec (PBP) financials
Results, ratios and statements
Fundamentals
Our data providers hold no financial statements for PBP (last checked 15 Oct 2026). The company's own filings are listed below.
Financial reports
The company's own filings, newest first
- Half Yearly Report and AccountsHalf Year Results28 Feb 2024via asx_announcements
- CEO AGM Address & Trading UpdateAgm Address15 Nov 2023via asx_announcements
- Annual Report to shareholdersAnnual Report13 Oct 2023via asx_announcements
- Notice of Annual General Meeting/Proxy FormAgm Address13 Oct 2023via asx_announcements
- Preliminary Final ReportAnnual Results25 Aug 2023via asx_announcements
- FY23 Results PresentationInvestor Presentation25 Aug 2023via asx_announcements
- HY23 Results PresentationInvestor Presentation24 Feb 2023via asx_announcements
- Half Yearly Report and AccountsHalf Year Results24 Feb 2023via asx_announcements
- Annual Report to shareholdersAnnual Report28 Oct 2022via asx_announcements
- Notice of Annual General Meeting/Proxy FormAgm Address28 Oct 2022via asx_announcements
Showing 10 of 51 reports